AVALON™ Grand Plus is a non-surgical filler which contains highly-purified hyaluronic acid (24 mg/ml) and lidocaine (0.3%) for anaesthetic effects.

It is designed to be injected into the deep dermis for the correction of moderate to severe facial wrinkles and folds , cheeks, chin augmentation and shaping of the contours of the face and jawline.

The viscous filler, AVALON™ Grand Plus is an ideal solution for the correction of thick skin and deep wrinkles and it is also efficient in restoring volume with results lasting from 12 – 18 months*.

*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure. 

Cross-linked Hyaluronic Acid in AVALON™ Fillers

MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharmaceuticals’ R&D Institute.

The cross-linking agent serves to connect hyaluronic acid chains to form a net.

Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.

Please note that on occasion product package design can change, we will always strive to show the present design where possible

*The majority of our products are designed for professional use by doctors and specialists, by purchasing said product(s) you agree to supply on request formal proof of medical/professional training. Said product(s) are not intended for personal or home use.